|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
22,790,000 |
Market
Cap: |
21.22(M) |
Last
Volume: |
563,483 |
Avg
Vol: |
249,715 |
52
Week Range: |
$0.502 - $7 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Durect is a biopharmaceutical company developing therapies derived from its Epigenetic Regulator Program. Larsucosterol (also known as DUR-928), a chemical entity in clinical development, is the primary candidate in Co.'s Epigenetic Regulator Program. A bioavailable small molecule, larsucosterol has been shown in both in vitro and in vivo studies to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival. Co. is conducting a double-blind, placebo-controlled Phase 2b clinical trial called AHFIRM, in which Co. is evaluating larsucosterol's life saving potential in patients with severe alcohol-associated hepatitis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
516,132 |
Total Buy Value |
$0 |
$0 |
$0 |
$301,757 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
19 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Robertson Judith J. |
Director |
|
2022-08-19 |
4 |
B |
$0.85 |
$8,000 |
D/D |
9,412 |
356,132 |
2.39 |
-59% |
|
Robertson Judith J. |
Director |
|
2022-08-18 |
4 |
B |
$0.85 |
$60,794 |
D/D |
71,531 |
346,720 |
2.39 |
-59% |
|
Robertson Judith J. |
Director |
|
2022-08-17 |
4 |
B |
$0.83 |
$8,615 |
D/D |
10,189 |
275,189 |
2.39 |
-59% |
|
Maderis Gail J |
Director |
|
2022-08-12 |
4 |
B |
$0.71 |
$17,993 |
I/I |
25,204 |
200,000 |
2.1 |
-53% |
|
Maderis Gail J |
Director |
|
2022-08-11 |
4 |
B |
$0.70 |
$17,322 |
I/I |
24,796 |
174,796 |
2.1 |
-47% |
|
Maderis Gail J |
Director |
|
2022-08-10 |
4 |
B |
$0.69 |
$54,661 |
I/I |
79,693 |
150,000 |
2.1 |
-45% |
|
Maderis Gail J |
Director |
|
2022-08-09 |
4 |
B |
$0.64 |
$45,158 |
I/I |
70,307 |
70,307 |
2.1 |
-40% |
|
Robertson Judith J. |
Director |
|
2022-05-26 |
4 |
B |
$0.39 |
$25,597 |
D/D |
65,000 |
265,000 |
2.39 |
40% |
|
Azab Mohammad |
Director |
|
2022-05-24 |
4 |
B |
$0.38 |
$11,638 |
D/D |
30,000 |
60,000 |
2.39 |
45% |
|
Farfel Gail M |
Director |
|
2022-05-18 |
4 |
B |
$0.41 |
$12,201 |
D/D |
29,911 |
100,000 |
2.39 |
35% |
|
Azab Mohammad |
Director |
|
2022-05-17 |
4 |
B |
$0.42 |
$8,407 |
D/D |
20,000 |
30,000 |
2.39 |
35% |
|
Azab Mohammad |
Director |
|
2022-05-16 |
4 |
B |
$0.38 |
$3,767 |
D/D |
10,000 |
10,000 |
2.31 |
50% |
|
Farfel Gail M |
Director |
|
2022-05-16 |
4 |
B |
$0.39 |
$9,811 |
D/D |
25,300 |
70,089 |
2.39 |
50% |
|
Farfel Gail M |
Director |
|
2022-05-13 |
4 |
B |
$0.40 |
$3,700 |
D/D |
9,250 |
44,789 |
2.31 |
27% |
|
Farfel Gail M |
Director |
|
2022-05-12 |
4 |
B |
$0.39 |
$585 |
D/D |
1,500 |
35,539 |
2.31 |
41% |
|
Farfel Gail M |
Director |
|
2022-05-11 |
4 |
B |
$0.40 |
$3,973 |
D/D |
9,950 |
34,039 |
2.31 |
42% |
|
Farfel Gail M |
Director |
|
2022-05-10 |
4 |
B |
$0.41 |
$950 |
D/D |
2,339 |
24,089 |
2.31 |
39% |
|
Farfel Gail M |
Director |
|
2022-05-10 |
4 |
B |
$0.40 |
$1,679 |
D/D |
4,250 |
21,750 |
2.31 |
39% |
|
Farfel Gail M |
Director |
|
2022-05-09 |
4 |
B |
$0.39 |
$6,906 |
D/D |
17,500 |
17,500 |
2.39 |
49% |
|
Jian Li |
InterimPrincipalAccountingOfcr |
|
2022-03-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,481 |
|
-34% |
|
Robertson Judith J. |
Director |
|
2022-03-14 |
4 |
B |
$0.59 |
$118,000 |
D/D |
200,000 |
200,000 |
2.39 |
-20% |
|
Garcia Peter S |
Director |
|
2021-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
70,000 |
|
-56% |
|
Benito Simon X |
Director |
|
2021-12-07 |
4 |
B |
$1.02 |
$20,360 |
D/D |
20,000 |
105,000 |
2.39 |
-54% |
|
Joice Judy R |
Sr. VP Operations & Corp QA |
|
2021-05-14 |
4 |
S |
$1.72 |
$103,682 |
D/D |
(60,137) |
34,832 |
|
25% |
|
Joice Judy R |
Sr. VP Operations & Corp QA |
|
2021-05-14 |
4 |
OE |
$0.73 |
$45,907 |
D/D |
60,137 |
94,969 |
|
- |
|
74 Records found
|
|
Page 1 of 3 |
|
|